Dietary compounds that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in HT29 colon

W G Kirlin1, J Cai, M J DeLong

  • 1Department of Biochemistry, Winship Cancer Center, Emory University, Atlanta, GA 30322, USA.

The Journal of Nutrition
|September 28, 1999
PubMed

Insights

Dietary compounds that boost detoxification enzymes (Phase 2 inducers) also trigger cancer cell death (apoptosis). This suggests a dual mechanism for cancer prevention beyond just eliminating carcinogens.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Dietary agents inducing Phase 2 enzymes are known for cancer chemoprevention via enhanced carcinogen elimination.
  • The precise mechanisms by which these dietary agents exert protective effects require further elucidation.

Purpose of the Study:

  • To investigate whether dietary Phase 2 enzyme inducers can directly induce apoptosis in human colon carcinoma cells.
  • To explore the relationship between Phase 2 enzyme induction and apoptosis in cancer cells.

Main Methods:

  • Human colon carcinoma (HT29) cells were treated with various Phase 2 inducers (benzyl isothiocyanate, allyl sulfide, dimethyl fumarate, butylated hydroxyanisole).
  • Apoptosis was assessed through morphological changes, flow cytometry (sub-G1 phase), caspase activation, DNA fragmentation, and TUNEL staining.
  • Cells were pretreated with sodium butyrate to induce differentiation and assess its effect on enzyme activity and apoptosis.

Main Results:

  • Several dietary Phase 2 inducers activated apoptosis in HT29 cells within concentration ranges that increased enzyme activity.
  • Sodium butyrate pretreatment enhanced both Phase 2 enzyme activity and the induction of apoptosis by these agents.
  • Confirmed apoptotic characteristics, including DNA fragmentation and caspase activation, were observed.

Conclusions:

  • Dietary Phase 2 inducers possess a potential cancer-protective mechanism involving direct induction of apoptosis in cancer cells, independent of enhanced carcinogen elimination.
  • This suggests that diets rich in these compounds may eliminate precancerous cells via apoptosis, offering a broader protective strategy against cancer development.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...